Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in preclinical and clinical laboratory, gene therapy, and cell therapy services for the pharmaceutical, medical device, and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry.

Charles River Laboratories International, Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

COM:CRIVER

Charles River Laboratories International, Inc.

Last Close

141.36

08/05 22:30

Market Cap

6.94B

Beta: -

Volume Today

989.97K

Avg: -

name

homepage url

country

crunchbase url

employee count

sector

industry

revenue

monthly webtraffic

monthly webtraffic growth

raised capital

Description

peer of

invested in

competitor of

Metrics